Form D · Biotechnology
JASTLabs Corp
Richmond Hill, A6 · CIK 0002131485
Offering snapshot reported Jun 2, 2026 · SEC filing
- Reported sold
- Yet to sell Offering amount: $50M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 2, 2026 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-585931
The Company may offer discounts to the offering price for persons that invest certain amounts. These discounts will be available at https://www.manhattanstreetcapital.com/jastlabs-d.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Jun 2, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sheldon Pettle | Director, Executive, Promoter |
| Michael Rubin | Director, Executive |
| Michael Silver | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
100 Mural Street Suite 200
Richmond Hill, A6, L4B 1J3
Richmond Hill, A6, L4B 1J3